doi: 10.1016/0002-9610(70)90024-3.
Encephalopathy after portacaval shunting managed with lactulose
- PMID: 5440784
- DOI: 10.1016/0002-9610(70)90024-3
Item in Clipboard
Encephalopathy after portacaval shunting managed with lactulose
Am J Surg.
1970 Feb.
No abstract available
Similar articles
-
Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.Acta Med Scand. 1970 May;187(5):337-46. doi: 10.1111/j.0954-6820.1970.tb02954.x. Acta Med Scand. 1970. PMID: 5526951 No abstract available.
-
[Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].Clin Ter. 1972 Dec 31;63(6):531-56. Clin Ter. 1972. PMID: 4656204 Italian. No abstract available.
-
[Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].Fortschr Med. 1972 Aug 31;90(24):837-48. Fortschr Med. 1972. PMID: 4639347 German. No abstract available.
-
Lactulose treatment of hepatic encephalopathy in outpatients.Arch Surg. 1971 Jan;102(1):25-7. doi: 10.1001/archsurg.1971.01350010027006. Arch Surg. 1971. PMID: 5538764 Clinical Trial. No abstract available.
-
[Pathogenesis and treatment of portal encephalopathy].Dtsch Med Wochenschr. 1971 Aug 27;96(35):1403-8. doi: 10.1055/s-0028-1110152. Dtsch Med Wochenschr. 1971. PMID: 4935702 Review. German. No abstract available.
Cited by
-
Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics.Gut. 1972 Nov;13(11):859-66. doi: 10.1136/gut.13.11.859. Gut. 1972. PMID: 4646289 Free PMC article.
-
Portacaval shunts.World J Surg. 1984 Oct;8(5):688-97. doi: 10.1007/BF01655764. World J Surg. 1984. PMID: 6390989 Review. No abstract available.
-
Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.Drugs. 1972;4(1):7-48. doi: 10.2165/00003495-197204010-00003. Drugs. 1972. PMID: 4564869 Review. No abstract available.
-
Subtotal portacaval shunt obliteration for chronic hepatic encephalopathy.Ann Surg. 1973 Mar;177(3):276-9. doi: 10.1097/00000658-197303000-00006. Ann Surg. 1973. PMID: 4692114 Free PMC article. No abstract available.
-
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.Cochrane Database Syst Rev. 2016 May 6;2016(5):CD003044. doi: 10.1002/14651858.CD003044.pub4. Cochrane Database Syst Rev. 2016. PMID: 27153247 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
